IRVINE, Calif., December 23, 2019 — Ascendiant Capital Markets, LLC (“Ascendiant”) announced today the closing of a $7,600,000 Private Placement for Outlook Therapeutics, Inc. (NasdaqCM: OTLK) of Cranbury, New Jersey. For a copy of the announcement, please click here.